This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_MALE_GENITAL_NAS_EXALLC for full statistics.
Malignant neoplasm of other and unspecified male genital organs
C3_MALE_GENITAL_NAS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
24 |
4. Check minimum number of eventsNone |
24 |
5. Include endpointsNone |
24 |
6. Filter based on genotype QC (FinnGen only) |
24 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified male genital organs
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of other and unspecified male genital organs, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of male genital organs
- malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
Not enough data for upset plot.
Not enough data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 24 | - | 24 |
| Unadjusted period prevalence (%) | 0.01 | - | 0.01 |
| Median age at first event (years) | 68.37 | - | 68.37 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011397) Hemoglobin [Presence] in Urine by Test strip
13
41
5.74
4.25
1.9
3.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
10
32
4.64
3.05
2.1
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
7
8.61
2.68
1.4
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
16
80
3.98
2.53
5.5
4.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
8
25
4.26
2.35
1.6
1.8
—
—
—
0
0
(4035726)
6
14
5.32
2.31
1.7
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
10
41
3.47
2.08
2.2
3.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
13
64
3.25
2.02
2.0
3.0
—
—
—
0
0
(3002256) Pathology report gross observation
7
23
3.86
1.98
1.1
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
12
4.95
1.92
43.0
8.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
10
50
2.71
1.41
2.6
3.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
6
24
2.98
1.40
2.7
3.5
umol/l
11.7
8.5
—
6
19
(3023368) Bacteria identified in Blood by Culture
13
75
2.60
1.39
3.9
4.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
12
67
2.58
1.36
2.8
2.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
18
3.22
1.36
1.4
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
19
136
2.90
1.31
4.9
4.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
19
139
2.75
1.30
38.0
26.2
g/l
329.1
333.4
0.99
19
139
(3037467) Urinalysis macro (dipstick) panel - Urine
18
128
2.62
1.28
4.0
4.4
—
—
—
0
0
(3015736) pH of Urine
12
71
2.38
1.17
2.1
3.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
11
68
2.14
0.92
4.0
3.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
6
32
2.16
0.89
37.7
8.1
mmol/l
-0.8
2.2
—
6
22
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
0
26
0.00
0.84
0.0
5.7
—
33.7
—
0
18
(3003694) ABO and Rh group [Type] in Blood
7
40
2.05
0.80
1.0
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
13
90
1.97
0.77
7.2
5.3
g/l
31.4
34.9
0.84
13
85
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
14
100
1.96
0.76
19.6
8.0
umol/l
13.2
15.7
0.33
14
95
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
16
124
1.87
0.70
4.4
4.3
%
23.4
22.5
—
6
63
(3030467) Casts [#/volume] in Urine by Automated count
11
74
1.90
0.69
4.0
2.8
e6/l
2.7
0.8
—
6
59
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
13
94
1.84
0.64
4.2
3.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
11
80
1.69
0.50
4.0
3.1
e6/l
595.4
61.5
—
6
65
(3012516) Albumin [Mass/volume] in Urine
5
74
0.59
0.44
2.2
3.3
mg/l
5.1
93.9
—
5
54
(42870588) Differential panel, method unspecified - Blood
10
73
1.63
0.43
10.9
7.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
0
16
0.00
0.43
0.0
4.6
—
0.3
—
0
6
(3025159) Blasts/100 leukocytes in Blood
0
16
0.00
0.43
0.0
4.7
—
1.6
—
0
5
(3002179) Metamyelocytes/100 leukocytes in Blood
0
16
0.00
0.43
0.0
4.4
—
0.2
—
0
5
(3019225) pH of Specimen
0
17
0.00
0.42
0.0
5.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
0
18
0.00
0.41
0.0
4.6
—
1.3
—
0
7
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
6
41
1.61
0.40
2.7
1.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
11
86
1.52
0.34
5.0
3.7
e6/l
4410.8
71.5
—
6
65
(40758558) Short blood count panel - Blood
8
60
1.50
0.34
8.6
6.9
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
0
11
0.00
0.22
0.0
2.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
0
11
0.00
0.22
0.0
2.4
—
2.7
—
0
6
(3022313) Gas panel - Capillary blood
0
10
0.00
0.22
0.0
4.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
0
13
0.00
0.21
0.0
3.8
—
0.1
—
0
13
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
1.8
—
0
8
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
17
181
0.79
0.20
5.0
5.6
mmol/l
5.8
6.3
2.22
17
159
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
17
181
0.79
0.20
5.6
6.0
mmol/l
2.4
2.4
0.04
17
161
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
19
172
1.50
0.20
21.3
18.6
ml/min/173m2
72.5
73.6
0.07
11
142
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
8
68
1.26
0.19
2.6
4.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
10
87
1.26
0.12
12.8
8.1
%
65.1
61.1
—
10
82
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
19
197
0.83
0.11
16.9
12.3
u/l
31.5
27.2
0.43
19
188
(3006504) Eosinophils/100 leukocytes in Blood
10
88
1.23
0.10
10.5
8.1
%
2.9
2.4
—
10
83
(3019069) Monocytes/100 leukocytes in Blood
10
88
1.23
0.10
10.5
8.5
%
9.0
9.0
—
10
83
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
17
176
0.88
0.09
5.6
7.7
mmol/mol
39.6
42.9
0.98
17
159
(3002030) Lymphocytes/100 leukocytes in Blood
10
90
1.19
0.07
12.8
8.1
%
19.2
24.0
—
10
85
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
11
107
1.05
0.00
2.6
3.4
u/l
219.6
66.7
0.37
11
100
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
5
57
0.85
0.00
1.6
1.6
mg/l
3.4
3.0
—
5
48
(3038515) Glucose [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
5.5
—
8.1
—
0
6
(3022806) Fractional oxyhemoglobin in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
88.9
—
0
6
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.3
—
64.7
—
0
6
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
6
0.00
0.00
0.0
1.3
—
5.0
—
0
6
(3008037) Lactate [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
5.5
—
1.5
—
0
6
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
0
8
0.00
0.00
0.0
4.9
—
—
—
0
0
(3013512) EKG study
6
58
1.05
0.00
1.8
5.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
11.3
—
0
7
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
17
163
1.15
0.00
10.9
8.1
u/l
81.5
84.4
0.11
17
156
(3016879) Cocaine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.5
—
55.3
—
0
8
(3004451) EKG impression Narrative
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
9
86
1.07
0.00
11.6
7.9
%
0.8
0.5
—
9
81
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
0
9
0.00
0.00
0.0
5.2
—
25.1
—
0
9
(3039443) Prostate specific Ag panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
9
0.00
0.00
0.0
6.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
9
91
0.98
0.00
2.3
2.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MALE_GENITAL_NAS – Malignant neoplasm of other and unspecified male genital organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).